| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 359.70K | $ 401.00K | $ 145.80K | $ 119.80K | $ 46.00K |
| Gross Profit | $ 335.86K | $ 372.93K | $ 145.80K | $ 119.80K | $ 46.00K |
| Operating Income | $ -15.65M | $ -11.56M | $ -15.22M | $ -18.86M | $ -26.31M |
| EBITDA | $ -14.03M | $ -8.79M | $ -14.97M | $ -13.10M | $ -42.40M |
| Net Income | $ -14.24M | $ -8.98M | $ -10.42M | $ -13.22M | $ -44.30M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.95M | $ 10.73M | $ 11.07M | $ 14.75M | $ 21.03M |
| Total Assets | $ 4.08M | $ 12.28M | $ 12.61M | $ 16.43M | $ 22.45M |
| Total Debt | $ 0.00 | $ 0.00 | $ 162.32K | $ 301.64K | $ 670.70K |
| Net Debt | $ -1.51M | $ -547.89K | $ -722.06K | $ -1.41M | $ -20.36M |
| Total Liabilities | $ 3.72M | $ 3.75M | $ 2.61M | $ 6.14M | $ 856.50K |
| Stockholders' Equity | $ 356.74K | $ 8.53M | $ 10.00M | $ 10.29M | $ 21.60M |
| Cash Flow | |||||
| Free Cash Flow | $ -10.91M | $ -8.34M | $ -6.60M | $ -6.35M | $ -3.36M |
| Operating Cash Flow | $ -10.79M | $ -8.23M | $ -6.43M | $ -5.91M | $ -3.33M |
| Investing Cash Flow | $ 8.90M | $ 514.53K | $ 3.25M | $ -13.40M | $ -30.66K |
| Financing Cash Flow | $ 2.85M | $ 7.38M | $ 2.35M | $ 0.00 | $ 21.32M |
BioRestorative Therapies Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.